In the Spotlight

Trial aims to demonstrate clinical benefit of innovative SonR® CRT optimization system in cardiac resynchronization therapy Milan, Italy, March 20, 2013 –Sorin Group, (Reuters Code: SORN.MI), a global medical device company and a leader in the treatment of cardiovascular ...+
Results published in EUROPACE show significant improvement in heart failure patients’ response to cardiac resynchronization therapy with Sorin’s innovative SonR®[1] automatic CRT optimization system Boston, US, May 9th, 2012 –Sorin Group, ...+
New pacing, defibrillation and left ventricular leads, combined with Sorin Group’s innovative implantable devices enable effective management of arrhythmias and heart failure. Boston, US, May 10th, 2012 –Sorin Group, (Reuters Code: SORN.MI), a global medical device ...+
SMARTVIEWTM remote monitoring combines intelligent cardiac device features and secure e-health technology to improve cardiac patients’ care and service to healthcare professionals Nice, France. June 13th, 2012. Sorin Group(Reuters Code: SORN.MI), a global ...+
Study evaluates sensitivity and positive predictive value of Sleep Apnea Monitoring (SAM) feature in implantable pacemakers Milan, Italy, June 12th 2012 – Sorin Group, (Reuters Code: SORN.MI), a global medical device company and a leader in the treatment of ...+

News

Events